Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial.
Apr 2010 - :1477-2566 [PMID:20429791]
[Trepiakas R] [Berntsen A] [Hadrup SR] [Bjørn J] [Geertsen PF] [Straten PT] [Andersen MH] [Pedersen AE] [Soleimani A] [Lorentzen T] [Johansen JS] [Svane IM]

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.
Sep 2008 - J. Immunother.; 31(8):1537-4513 [PMID:18779742]
[Berntsen A] [Trepiakas R] [Wenandy L] [Geertsen PF] [thor Straten P] [Andersen MH] [Pedersen AE] [Claesson MH] [Lorentzen T] [Johansen JS] [Svane IM]

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
Jun 2007 - Cancer Immunol. Immunother.; 56(9):0340-7004 [PMID:17285289]
[Svane IM] [Pedersen AE] [Johansen JS] [Johnsen HE] [Nielsen D] [Kamby C] [Ottesen S] [Balslev E] [Gaarsdal E] [Nikolajsen K] [Claesson MH]